Johnson & Johnson (BCBA:JNJ)

Market Cap	754.06T
Revenue (ttm)	122.42T
Net Income (ttm)	33.37T
Shares Out	n/a
EPS (ttm)	13,747.19
PE Ratio	22.60
Forward PE	19.93
Dividend	277.59 (1.26%)
Ex-Dividend Date	Nov 25, 2025

Volume	24,219
Average Volume	9,621
Open	22,150
Previous Close	21,980
Day's Range	21,690 - 22,270
52-Week Range	11,100 - 22,900
Beta	0.33
RSI	63.81
Earnings Date	Jan 21, 2026

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizo...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1886
• Employees: 138,100
• Stock Exchange: Buenos Aires Stock Exchange
• Ticker Symbol: JNJ

Financial Performance

In 2025, Johnson & Johnson's revenue was $94.19 billion, an increase of 6.05% compared to the previous year's $88.82 billion. Earnings were $26.80 billion, an increase of 90.56%.

Financial numbers in USD